University of Minnesota. Driven to Discover.
Also, tens of thousands of federal workers have requested vaccine exemptions on religious grounds.
For the third week in a row, illness numbers in Europe rose, with a 7% jump last week.
UN agencies warn of erosions on schooling in West Asia, as well as on employment and maternal health in Latin America.
Also, a US probe into the source of SARS-CoV-2 was inconclusive, with worries that time is running out to discover the origin.
In another development, the WHO announced the next phase of a treatment trial, which will test three repurposed drugs across 52 countries.
In the northern Amazon basin where cases are spiking, ICUs in Brazil, Peru, and Colombia are filling up with COVID-19 patients.
In other developments, 70 countries have now detected the B117 variant, and more nations have also reported the 501Y.V2 and P.1 variants.
The number of Americans hospitalized with COVID-19 continues a record-breaking rise.
The head of the WHO warns about "vaccine nationalism" and previews a basic strategy for deploying vaccine.
Efforts are under way to use PAHO funds to help nations buy vaccine, and the group is advising them on trial participation.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2022 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.